Laboratorio Reig Jofre, S.A. (BME: RJF)

Market Cap	222.57M
Revenue (ttm)	333.55M
Net Income (ttm)	9.27M
Shares Out	80.06M
EPS (ttm)	0.12
PE Ratio	23.64
Forward PE	19.86
Dividend	0.04 (1.44%)
Ex-Dividend Date	May 17, 2024

Volume	2,200
Open	2.790
Previous Close	2.780
Day's Range	2.720 - 2.810
52-Week Range	2.150 - 3.380
Beta	0.92
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 31, 2024

About Laboratorio Reig Jofre

Laboratorio Reig Jofre, S.A., a pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products and specialties, as well as accessories authorized foodstuffs, dietary and personal care products, and cosmetics. The company offers nutritional and parapharmacy products. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint health and pain, and women’s health; an...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1929
• Employees: 1,323
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: RJF

Financial Performance

In 2023, Atrys Health's revenue was 206.10 million, an increase of 26.28% compared to the previous year's 163.20 million. Losses were -45.59 million, 97.0% more than in 2022.